H3K9 methylation drives resistance to androgen receptor–antagonist therapy in prostate cancer
收藏NIAID Data Ecosystem2026-03-13 收录
下载链接：
https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE202335
下载链接
链接失效反馈官方服务：
资源简介：
The study was performed to identify the role of H3K9 methylation in prostate cancer. This experiment was conducted to determine the genomic localization of H3K9me2 and H3K9me3 in naïve, short-term antiandrogen treated and antiandrogen resistant prostate cancer cells. Chromatin immunoprecipitation DNA-sequencing (ChIP-seq) for histone modifications H3K9me2 and H3K9me3 in naïve LNCaP, short-term antiandrogen treated LNCaP and LNCaP EnzR cells.
创建时间：
2022-06-23
